During a hearing on federal welfare reform held by the House Ways and Means Committee on Tuesday, legendary quarterback Brett Favre revealed that he has recently been diagnosed with Parkinson's disease, a disorder that impacts the central nervous system and movement.
"Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others," the 54-year-old Favre said during his opening statement. "I'm sure you'll understand, while it's too late for me because I've recently been diagnosed with Parkinson's, this is also a cause dear to my heart."
After 20 seasons in the NFL, Favre explained to the "The Bubba Army" radio show in 2022 that he had suffered thousands of concussions, and he emphasized during an interview with Megyn Kelly in 2018 that he has had difficulty with his short-term memory and word retrieval, as reported by The New York Post.
Favre spoke before the committee on his involvement with Prevacus, a company that received $2 million in Temporary Assistance for Needy Families (TANF) funding to develop a concussion drug. The company's founder, Jacob VanLandingham, was found guilty of wire fraud in July for spending the welfare funds to pay off personal debts. During his testimony, Favre, a top Prevacus investor, explained that the welfare funds were abused and used to transfer tens of millions of dollars from Mississippi's poorest residents to the rich.
During his opening statement before Congress, @BrettFavre says he's recently been diagnosed with Parkinson’s disease.
— CSPAN (@cspan) September 24, 2024
Full video here: https://t.co/bANW0t3SK6 pic.twitter.com/IFQzqC847M
You can follow Sterling on X/Twitter here.
Violent Venezuelan Gang Reportedly Attacked Border Crossings As Concerns Mount About More Possible Violence
Woman Allegedly Burned Alive On Train By Illegal Migrant Finally Identified
Biden Admin Invoked ‘Indigenous Knowledge’ To Cut Alaska Drilling, But Some Tribal Leaders Are Ready For Trump
Powered by StructureCMS™ Comments
Comments